Panel Discussion: Scaling Autoimmune Cell Therapies: Overcoming Manufacturing Challenges to Improve Speed, Cost, & Reproducibility
- Cell therapy place in autoimmune disease, significance and cost appropriateness
- Examining both ex vivo and in vivo approaches, highlighting the trade-offs between customized manufacturing and off-the-shelf therapies
- Evaluating current GMP-level processes which remain largely manual, creating bottlenecks in speed, cost, and reproducibility
- Discussing automated technologies, such as advanced cell sorters and bioreactors, that could streamline manufacturing